Vita Coco's Roper Sells at $50 — Koch Family Holds 21.6%

Martin Roper, Chief Executive Officer of The Vita Coco Company (COCO), filed Form 4 transactions across multiple April 2026 windows — option exercise + sale sequences executing at $50 per share against a $10.18 strike. The pattern across April 16, 24, and 27 shows the same structure: 25,000 shares M-coded at $10.18 strike, 25,000 shares S-coded at $50.00. Net economic outcome approximately $40 per share gross before tax withholding — a 393% per-option markup on the strike price.

The execution pattern is plan-driven 10b5-1 cashless exercise — recurring 25,000-share blocks at identical $50 sale price across multiple plan dates. (See our Form 4 cashless exercise reading guide for the M+S signature framework.) Cumulative recorded sales over Roper's full tenure as a public-company CEO total $283.6 million across 2,955 transactions, with $1.4 million of recorded purchases on the buy side. The April 2026 batches added approximately $7-8 million in incremental distribution.

The Vita Coco Holder Concentration

The structural feature of COCO's holder file is concentration. The most recent Schedule 13G/A filings reveal:

• KOCH C JAMES filed Schedule 13G/A on February 11, 2026 disclosing 21.62% beneficial ownership of 2,271,472 shares. This is one of the largest concentrated single-shareholder positions in any consumer-staples mid-cap. The Koch C James filing represents a private investor's controlling-tier stake; the position has scaled from 19.99% in February 2025 to 21.62% in February 2026.
• Vanguard Group Inc. filed Schedule 13G/A on January 30, 2026 disclosing 12.09% beneficial ownership of 1,039,184 shares — mechanical index-fund accumulation as COCO's index-eligibility scaled.
• AQR Capital Management LLC filed Schedule 13G/A on February 12, 2026 disclosing 5.12% beneficial ownership of 440,224 shares — quantitative-systematic positioning past the threshold.
• The earlier AQR Capital 13G filing (November 14, 2025) had disclosed 7.34% — implying AQR has trimmed approximately 200 basis points of position over the trailing quarter, a meaningful systematic-flow rebalance.

The combined picture: 21.6% Koch C James + 12.1% Vanguard + 5.1% AQR = approximately 38.8% of beneficial ownership concentrated in three named filers. The float available for active institutional trading is structurally constrained.

Why the Koch Concentration Matters

For a $1B+ market-cap consumer-staples mid-cap, having a single private investor at 21.6% concentrated ownership creates specific structural dynamics:

• Acquisition-target dynamics. Concentrated single-shareholder structures often signal eventual sale-of-company outcomes. The Koch family has historical strategic-investor relationships in consumer staples; the 21.6% position would be a meaningful blocking or controlling stake in any M&A scenario.
• Float-driven price volatility. With ~38% of outstanding shares concentrated in three top filers, the actual tradable float is meaningfully smaller than the headline market cap suggests. Quarterly 13G adjustments in Vanguard or AQR positions can move the equity disproportionately.
• Roper's plan-driven distribution lands into structural support. Roper's M+S cashless exercise sales at $50 are absorbed by a holder set with concentrated single-shareholder demand. The plan-driven supply is matched by structural-investor accumulation rather than by general market clearing.

The 13D/G Tape Versus a Hypothetical 13D

Notable absence: Koch C James files Schedule 13G, not 13D. (For background, see our 13G versus 13D filings reading guide.) The 13G filing means the holder is passive — accumulation past 5% without intent to influence control. A future conversion from 13G to 13D would signal a structural shift from passive concentrated stake to activist intent. (See our 13G to 13D conversion reading guide.) Investors can verify the underlying records via SEC EDGAR's 13D/G page for The Vita Coco Company (CIK 0001722438).

The April Cashless-Exercise Math

The economic math on Roper's April 2026 transactions illustrates how 10b5-1 cashless exercise plans work in practice:

• Exercise 25,000 options at $10.18 strike = $254,500 exercise cost.
• Sell 25,000 shares immediately at $50.00 market price = $1,250,000 proceeds.
• Net pre-tax economic gain per tranche = $995,500 (approximately $40 per share gross).
• Three identical tranches across April 16, 24, and 27 = roughly $3 million pre-tax across the month.

This is mechanical compensation realization, not a discretionary view on Vita Coco's commercial trajectory. Discretionary view-driven framing on this kind of transaction pattern would be factually wrong.

The Operational Cross-Check

Roper's continued role as CEO, combined with continued operational engagement (earnings calls, brand-strategy decisions, distribution-relationship management with retail partners), signals continued strategic alignment despite the systematic Form 4 sales footprint. The 375,214 shares Roper holds directly post the April 27 sale is meaningful operational alignment for a consumer-staples CEO at this market-cap tier.

The Forward Read

For investors using Form 4 + Schedule 13G/A data on Martin Roper and Vita Coco, three concrete reads:

• Treat the April M+S sequences as plan-driven cashless exercise. The 393%-per-option economics are mechanical — a function of Vita Coco's IPO-era option strikes meeting current $50 market price, not a tactical signal.
• The Koch C James 21.62% concentration is the most informative structural feature on COCO. Watch for any 13G/A amendment that would signal shift in concentration — particularly any future conversion to 13D filing, which would signal change in passive-to-active intent.
• The AQR Capital trim from 7.34% to 5.12% over Q4-Q1 is the most informative recent flow signal. Watch for additional AQR 13G/A amendments — quantitative-systematic flow shifts often precede broader institutional rebalances.

See Martin Roper's full Form 4 transaction history on 13F Insight →